Top stories from cell/gene therapy confab; 2032 deadline to decouple; Patient death in Pfizer trial; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

We’ve seen so much news this week that I al­most can’t be­lieve some sto­ries fea­tured be­low were from Mon­day. Be sure to read to the bot­tom in case you missed any­thing.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.